In this GEN webinar, our expert speakers will explore cutting-edge drug discovery techniques for target deconvolution and multiplex target discovery.

Fast Track designation designed to facilitate the development, and expedite the review, of drugs to treat serious conditions ...

Swiss biotech AC Immune has said that its vaccine-like alpha-synuclein-targeted immunotherapy has shown promise in slowing ...

Rezolute, Inc. is downgraded to a Sell after its phase 3 sunRIZE trial for congenital hyperinsulinism failed. Learn more ...

Topline final safety and efficacy results for the full 36 weeks of treatment from all participants will be available in ...

Study to evaluate safety and efficacy of novel anti-PRLR antibody; interim data anticipated in the second half of 2026 Trial design leverages operational synergies to enable accelerated registrational ...

Phase II ARCHER trial showed a significant reduction in left ventricular (LV) mass (p=0.0117) and improvements in multiple key cardiac MRI (CMR) measures of structural heart recovery in patients with ...

Discover why Mirum Pharmaceuticals, Inc. stock surged 65%. Explore robust pipeline growth, revenue outlook, and analyst ...

The U.S. Department of Health and Human Services on Thursday unveiled a series of regulatory actions designed to effectively ...

It's the 22nd strike the US military has carried out against boats that the Trump administration claimed were trafficking ...

Medicines enabled by NIH funding have been crucial for increasing life expectancy and health – dramatically decreasing deaths due to heart disease and stroke, improving cancer outcomes, controlling ...

Much of Walsh's time in office has focused on "quality-of-life fixes that make daily life better," as an observer put it.